3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
6
Neoplasms
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Cognitive Dysfunction
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Interventions
lutetium Lu 177 dotatate
5
Data Collection
3
telotristat ethyl
2
Somatostatin
2
Positron-Emission Tomography
2
Magnetic Resonance Spectroscopy
2
Everolimus
2
Drug Therapy
2
Biopsy
2
surufatinib
1
lanreotide
1
copper dotatate CU-64
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sorafenib
1
Salvage Therapy
1
Radionuclide Imaging
1
Radiomics
1
Radiofrequency Ablation
1
Quality of Life
1
Plastic Surgery Procedures
1
Phlebotomy
1
Patient Reported Outcome Measures
1
Octreotide
1
Molecular Diagnostic Techniques
1
Lutetium-177
1
Lutetium
1
Liver Transplantation
1
Laparoscopy
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neuroendocrine Tumors
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled